BMYMP - Bristol Plavix Setback And Other News: The Good Bad And Ugly Of Biopharma
Bristol-Myers Squibb Faces Setback in Plavix Litigation
Bristol-Myers Squibb (BMY) reported that a Hawaii district court has dismissed its countersuit against the State of Hawaii. The company is currently in an altercation with the state with regard to Plavix drug and its marketing. The Plavix trial is scheduled to be started in May 5, but it is highly likely that the date may now be postponed on account of COVID-19 pandemic. The company is fighting against an $8 billion lawsuit by Hawaii pertaining marketing of Plavix.
Bristol-Myers Squibb contends that the state is infringing upon